Samjin Pharmaceuticals Co., Ltd. (005500.KS) KSC

19,540.00

-20(-0.10%)

Updated at October 20 09:52AM

Currency In KRW

Valuation

Market Cap227.9B
Enterprise Value345.9B
P/E Ratio12.14
PEG Ratio-0.25
Price/Sales Ratio0.77
Price/Book Ratio0.93
Enterprise/Revenue1.18
Enterprise/EBITDA5.95

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.1

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue308.35B
Revenue/Share25,349.62
Gross Profit128.97B
EBITDA65.92B
Net Income39.23B
Diluted EPS3,110.66

Balance Sheet

Total Cash5.14B
Total Cash/Share419.47
Total Debt131.31B
Total Debt/Equity0.51
Current Ratio1.21
Book Value Per Share21,085.07

Price History

52-Week Change3.82
52-Week High21,300
52-Week Low16,590
Moving Average 50 Days19,426.6
Moving Average 200 Days18,516.55

Statistics

Average Volume37,080
Shares Outstanding12.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate800
Trailing Annual Dividend Yield4.09
Payout Ratio0
Last Split Factor103121:100000
Last Split DateDecember 29, 2010